Lipella Pharmaceuticals Inc. Contract with Customer, Asset, Sale
Lipella Pharmaceuticals Inc. (LIPO) reported Contract with Customer, Asset, Sale of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes
us-gaap:ContractWithCustomerAssetSale · last filed 2025-03-28
- Lipella Pharmaceuticals Inc. contract with customer, asset, sale for fiscal 2024 was $0.00.
- Lipella Pharmaceuticals Inc. contract with customer, asset, sale for fiscal 2023 was $0.00.
- Lipella Pharmaceuticals Inc. contract with customer, asset, sale for fiscal 2022 was $0.00.
- Lipella Pharmaceuticals Inc. contract with customer, asset, sale for fiscal 2021 was $0.00.
| Period end | Contract with Customer, Asset, Sale 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-28 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-27 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |